{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T10:40:17Z","timestamp":1782297617702,"version":"3.54.5"},"reference-count":24,"publisher":"Ubiquity Press, Ltd.","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"World Heart Federation Emerging Leader Program"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["gh"],"DOI":"10.1016\/j.gheart.2019.07.006","type":"journal-article","created":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T20:09:55Z","timestamp":1566590995000},"page":"327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Equivalence in Active Pharmaceutical Ingredient of Generic\n                        Antihypertensive Medicines Available in Nigeria (EQUIMEDS): A Case for\n                        Further Surveillance"],"prefix":"10.5334","volume":"14","author":[{"given":"Julie","family":"Redfern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harparkash","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rufus Adesoji","family":"Adedoyin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Ofori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghupathy","family":"Anchala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay S.","family":"Vamadevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"De Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Zelaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Balabanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud Umar","family":"Sani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3285","published-online":{"date-parts":[[2019,9,1]]},"reference":[{"key":"10.1016\/j.gheart.2019.07.006_bib1","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0140-6736(12)60861-7","article-title":"Hypertension in developing countries","volume":"380","author":"Ibrahim","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.gheart.2019.07.006_bib2","series-title":"Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks","year":"2009"},{"key":"10.1016\/j.gheart.2019.07.006_bib3","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/S0140-6736(12)61766-8","article-title":"A\u00a0comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lim","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.gheart.2019.07.006_bib4","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.gheart.2019.07.006_bib5","doi-asserted-by":"crossref","first-page":"e561","DOI":"10.1016\/S2214-109X(14)70189-5","article-title":"Improving global access to medicines for non-communicable diseases","volume":"2","author":"Beran","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.gheart.2019.07.006_bib6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12936-016-1096-x","article-title":"Fake anti-malarials: Start with the facts: meeting report summary","volume":"15","author":"Kaur","year":"2016","journal-title":"Malar J"},{"key":"10.1016\/j.gheart.2019.07.006_bib7","doi-asserted-by":"crossref","first-page":"e7381","DOI":"10.1136\/bmj.e7381","article-title":"How to achieve international action on falsified and substandard medicines","volume":"345","author":"Attaran","year":"2012","journal-title":"Br Med J"},{"key":"10.1016\/j.gheart.2019.07.006_bib8","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1371\/journal.pmed.0020100","article-title":"The global threat of counterfeit drugs: why industry and governments must communicate the dangers","volume":"2","author":"Cockburn","year":"2005","journal-title":"PLoS Med"},{"key":"10.1016\/j.gheart.2019.07.006_bib9","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1371\/journal.pmed.0030197","article-title":"Manslaughter by fake artesunate in Asia\u2014will Africa be next?","volume":"3","author":"Newton","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.gheart.2019.07.006_bib10","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S1473-3099(06)70581-3","article-title":"Counterfeit anti-infective drugs","volume":"6","author":"Newton","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.gheart.2019.07.006_bib11","doi-asserted-by":"crossref","first-page":"552","DOI":"10.4269\/ajtmh.2008.78.552","article-title":"Impaired clinical response in a patient with uncomplicated falciparum malaria who received poor-quality and underdosed intramuscular artemether","volume":"78","author":"Keoluangkhot","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.gheart.2019.07.006_bib13","doi-asserted-by":"crossref","first-page":"e002923","DOI":"10.1136\/bmjopen-2013-002923","article-title":"Substandard and counterfeit medicines: a systematic review of the literature","volume":"3","author":"Almuzaini","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.gheart.2019.07.006_bib14","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S1473-3099(15)00402-8","article-title":"Mission Indradhanush and the counterfeit drug trade in India","volume":"15","author":"Banerjee","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.gheart.2019.07.006_bib15","series-title":"Counterfeit Medicines in Less Developed Countries: Problems and Solutions","author":"Morris","year":"2006"},{"key":"10.1016\/j.gheart.2019.07.006_bib18","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1371\/journal.pmed.1000052","article-title":"Guidelines for field surveys of the quality of medicines: a proposal","volume":"6","author":"Newton","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.gheart.2019.07.006_bib21","first-page":"149","article-title":"Hypertension prevalence in an Urban and Rural area of Nigeria","volume":"4","author":"Sola","year":"2013","journal-title":"J\u00a0Med Med Sci"},{"key":"10.1016\/j.gheart.2019.07.006_bib22","doi-asserted-by":"crossref","first-page":"e104300","DOI":"10.1371\/journal.pone.0104300","article-title":"Estimating the prevalence and awareness rates of hypertension in Africa: a systematic analysis","volume":"9","author":"Adeloye","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.gheart.2019.07.006_bib23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2261-13-54","article-title":"Hypertension awareness, treatment and control in Africa: a systematic review","volume":"13","author":"Kayima","year":"2013","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.gheart.2019.07.006_bib24","doi-asserted-by":"crossref","first-page":"e000086","DOI":"10.1136\/bmjgh-2016-000086","article-title":"Physico-chemical equivalence of generic antihypertensive medicines (EQUIMEDS): protocol for a quality of medicines assessment","volume":"1","author":"Redfern","year":"2016","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.gheart.2019.07.006_bib26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.gheart.2015.04.006","article-title":"Reducing cardiovascular mortality through prevention and management of raised blood pressure: a World Heart Federation roadmap","volume":"10","author":"Adler","year":"2015","journal-title":"Global Heart"},{"key":"10.1016\/j.gheart.2019.07.006_bib27","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/bcp.12298","article-title":"Substandard drugs: a potential crisis for public health","volume":"78","author":"Johnston","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.gheart.2019.07.006_bib28","doi-asserted-by":"crossref","first-page":"776","DOI":"10.4269\/ajtmh.2009.09-0109","article-title":"Influence of tropical climate conditions on the quality of antihypertensive drugs from Rwandan pharmacies","volume":"81","author":"Twagirumukiza","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.gheart.2019.07.006_bib29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/HJH.0000000000001560","article-title":"Substandard drugs among five common antihypertensive generic medications: an analysis from 10 African countries","volume":"36","author":"de Terline","year":"2018","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.gheart.2019.07.006_bib30","doi-asserted-by":"crossref","first-page":"993","DOI":"10.4269\/ajtmh.15-0665","article-title":"Degradation of artemisinin-based combination therapies under tropical conditions","volume":"94","author":"Hall","year":"2016","journal-title":"Am J Trop Med Hyg"}],"container-title":["Global Heart"],"original-title":[],"link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221181601930119X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221181601930119X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/doi.org\/10.1016\/j.gheart.2019.07.006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T12:50:16Z","timestamp":1657543816000},"score":1,"resource":{"primary":{"URL":"https:\/\/globalheartjournal.com\/article\/10.1016\/j.gheart.2019.07.006\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,1]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,9,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.gheart.2019.07.006","relation":{},"ISSN":["2211-8179","2211-8160"],"issn-type":[{"value":"2211-8179","type":"electronic"},{"value":"2211-8160","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Equivalence in Active Pharmaceutical Ingredient of Generic Antihypertensive Medicines Available in Nigeria (EQUIMEDS)","name":"articletitle","label":"Article Title"},{"value":"Global Heart","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gheart.2019.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 World Heart Federation (Geneva). Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}